SHANE COX: Open Payments
NPI 1780264226 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,177 in 131 payments from 16 companies in 2025. Trend: 2023 $464 · 2024 $873 · 2025 $2,177
Food & beverage: $2,093Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $414 |
| ABBVIE INC. | 25 | $330 |
| Ardelyx, Inc. | 18 | $293 |
| Phathom Pharmaceuticals, Inc. | 16 | $210 |
| Madrigal Pharmaceuticals | 12 | $161 |
| QOL Medical, LLC | 6 | $153 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $136 |
| Ipsen Biopharmaceuticals, Inc | 4 | $103 |
| Aimmune Therapeutics, Inc. | 7 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $73 |
Products named: TREMFYA, IBSRELA, VOQUEZNA, REZDIFFRA, Sucraid, Linzess, IQIRVO, VIBERZI.
Industry payments across AL — which companies pay providers there.
